Opal Computational Platform News Today

Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The

Former Ernst and Young Senior Partner to serve as Chair of Audit Committee BOSTON, Jan. 4, 2024 /PRNewswire/ -- Valo Health, Inc , a technology company focused on utilizing large scale data and...

Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The

Novo Nordisk and Valo Health have entered into an agreement to discover and develop novel treatments for cardiometabolic diseases.

Novo Nordisk A/S and Valo Health, Inc. announced they have entered into an agreement to discover and develop novel treatments for cardiometabolic diseases based on Valo’s large human dataset and computation powered by artificial intelligence (AI). The collaboration between the two organizations will leverage the capabilities of Valo’s Opal Computational Platform™ including access to real-world patient data, AI-enabled small molecule discovery and Biowire® human tissue modelling platform ...

Denmark’s Novo Nordisk struck a deal with U.S.-based health tech firm Valo Health to use AI to discover and develop treatments for cardiometabolic diseases such as heart attack, stroke, and diabetes.

Collaboration will apply Valo’s Opal Computational Platform™ and real-world patient dataset to enable the discovery and development of novel cardiometabolic drug programmes Novo Nordisk...

WILMINGTON, Mass. & DENVER--(BUSINESS WIRE)--Sep 14, 2023--

/PRNewswire/ -- Valo Health, Inc. ("Valo"), the technology company focused on transforming the drug discovery and development process using human-centric data...

/PRNewswire/ -- Valo Health, LLC ("Valo"), announced today the acquisition of TARA Biosystems, Inc. ("TARA"), a New York City-based cardiovascular disease...